Avalo Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio176.293.792.6335.37628.78
P/B Ratio0.581.00-4.358.27171.49
Price/Tangible Book0.6322.11491.62
Enterprise Value Ratios
EV/Revenue2.8728.36624.02
Profitability & Returns
Return on Equity (ROE)-0.50%-6.85%-3.54%-2.83%
Return on Assets (ROA)-0.30%-0.54%-0.33%-0.83%-0.74%
Return on Invested Capital (ROIC)-68.35%-42.62%-15.02%-3.67%
Return on Capital Employed (ROCE)-0.28%-1.43%-2.66%-1.36%-1.66%
Leverage & Solvency Ratios
Debt/Equity0.010.26-1.981.530.06
Liquidity Ratios
Current Ratio19.951.820.743.111.71
Quick Ratio19.421.640.682.991.53
Efficiency Ratios
Asset Turnover0.010.070.320.090.17
Inventory Turnover896.212444.832074.05
Yield & Distribution Ratios
Earnings Yield-0.45%-4.32%-0.88%-0.44%-0.02%
FCF Yield-0.63%-4.23%-0.57%-0.37%-0.01%
Buyback Yield-25.99%-6.08%-0.08%-0.42%-0.29%